• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Murchinson Nominates Two Highly Qualified Candidates to Nano Dimension's Board of Directors

    10/28/24 4:05:00 PM ET
    $DM
    $INSG
    $MCK
    $MKFG
    Industrial Machinery/Components
    Technology
    Telecommunications Equipment
    Telecommunications
    Get the next $DM alert in real time by email

    Believes Nano's Ongoing Value Destruction, Worst-In-Class Corporate Governance and Misallocation of Corporate Resources Warrants Urgent Change in Company's Boardroom

    Murchinson's Nominees Would Bring Independent Perspectives and Relevant Experience to Restore Shareholders' Confidence in Leadership, Establish Appropriate Capital Allocation Processes, Hold Management Accountable and Oversee Strategy Development and Implementation

    Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.1% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today announced it has nominated two director candidates – Robert (Bob) Pons and Ofir Baharav – for election to the Nano Board of Directors (the "Board") at the upcoming 2024 Annual General Meeting of Shareholders (the "2024 Annual Meeting"), scheduled for December 6, 2024.

    In addition to its director nominations, Murchinson has also submitted proposals for inclusion on the agenda for the 2024 Annual Meeting related to amendments and additions to the Company's Articles of Association.

    Murchinson stated:

    "For the past two years, we have been advocating for changes in the Nano boardroom that are critical in order to protect and create long-term shareholder value. In March 2023, Nano shareholders sent a clear message when they voted overwhelmingly at the special general meeting we called in favor of removing CEO Yoav Stern, Oded Gera, Igal Rotem and Yoav Nissan-Cohen from the Board. Despite 85% of voting shareholders voting to remove them, Messrs. Stern, Gera and Nissan-Cohen have refused to recognize these results and depart the Board.

    Since then, Nano has gone to great lengths to ignore this clear desire for change and disenfranchise shareholders, including by manipulating the voting process at last year's annual general meeting of shareholders and weaponizing the legal systems in Israel and the U.S. at shareholders' expense. While we are confident that the merits of our case will prevail, we cannot wait for the Israeli Court's decision. Despite Nano's so-called "refreshment" of the Board, it is clear to us that the problems identified by Murchinson persist and the Board remains subservient to Mr. Stern.

    Nano's Board has demonstrated that it is unable to improve the Company's valuation. The Company's share price is stagnant and the Board, having spent approximately $160 million on share repurchases, appears to have no ideas to improve it.

    The Board has shown that it is incapable of holding management accountable. The proposed compensation package for Mr. Stern, which we find offensive because, among other things, it is misaligned with actual performance, confirms that the Board is not protecting shareholders' interests nor properly overseeing management.

    The Board's actions reveal that it lacks the necessary judgment to use Nano's cash and other resources responsibly. Between the related-party acquisition of DeepCube from two sitting directors at an inflated value in 2021, the overpriced, misguided acquisitions of Desktop Metal, Inc. (NYSE:DM) and Markforged Holding Corp. (NYSE:MKFG), and management's demonstrated inability to integrate acquired businesses and generate synergies, there is compelling evidence that additional independent voices with M&A experience are needed.

    When a publicly traded company is valued at a discount to its cash, shareholders are signaling that they do not believe the company's leadership can create value. This persistent negative enterprise value reveals that the Nano Board either does not care or is not able to convince shareholders otherwise.

    Our experienced and independent nominees are:

    • Robert (Bob) Pons, who has more than four decades of experience as a CEO and senior executive at high-growth technology companies, as well as corporate governance expertise and unique turnaround insights from service on more than sixteen public company boards.
    • Ofir Baharav, who was a Nano Dimension director from 2015 to 2021, including as Chairman from 2019 to 2021, has a career spanning more than two decades in the technology and 3D printing sector, including as VP Product Management of Nano's competitor Stratasys Ltd. (NASDAQ:SSYS), and brings experience in M&A, operational improvements, product development, corporate governance and enhancing shareholder value.

    By electing these nominees, shareholders will be adding independent, objective directors with the right skills and experience to help the Company implement a long-overdue solution to its significant valuation issue and ensure the Company's resources are used to advance shareholders' interests. Importantly, these director candidates are not beholden to Mr. Stern and are committed to acting in accordance with their fiduciary duties at all times.

    We look forward to sharing more with our fellow shareholders in the near-term, including evidence that the Board's priorities are in direct conflict with shareholders' best interests."

    ***

    Biographies of Murchinson's Nominees

    Robert (Bob) Pons

    Mr. Pons has more than four decades of experience as a CEO and senior executive in high-growth companies. He brings significant corporate governance expertise having served on the boards of more than sixteen publicly traded companies. Nano shareholders will benefit from adding his experience as a turnaround specialist to the Board.

    • Served as President and Chief Executive Officer of Spartan Advisors, Inc., a management consulting firm specializing in telecom and technology companies, since 2017.
    • Previously served as Executive Vice President of PTGi-ICS, a wholly owned subsidiary of HC2 Holdings, Inc., a publicly traded holding company operating subsidiaries in infrastructure, telecom, construction, energy, technology, gaming and life sciences.
    • Public boards experience includes roles as Executive Chairman of SeaChange International, Inc. (NASDAQ:SEAC) as well as Director at CCUR Holdings, Inc. (OTCPK: CCUR), Alaska Communications, Inc., Inseego Corp. (NASDAQ:INSG) and MRV Communications, Inc.

    Ofir Baharav

    Mr. Baharav is a seasoned senior executive with a career spanning more than two decades in product development for the technology and 3D printing sector. In his various public company director roles, he has focused on M&A, operational improvements, corporate governance and enhancing shareholder value.

    • Previously served as Chairman of the Nano Dimension Board from 2019 to 2021, and as a director at the Company from 2015 to 2021 (during which period Nano was valued at a premium to its cash). Prior to Nano, from 2014 to 2015, Mr. Baharav was VP, Product Management of Stratasys Ltd. (NASDAQ:SSYS), where he led the turnaround and redesign of Stratasys' flagship product.
    • Currently serves as Chief Executive Officer of Maxify Solutions, Inc., which he founded in 2022 to acquire the assets of Breezer Holdings LLC and SimiGon Inc.; was SimiGon Inc.'s CEO from 2016 to 2022.
    • Founded RelayHealth Corporation in 1999 and served as CEO until it was acquired by McKesson Corp. (NYSE:MCK) in 2006.

    ***

    About Murchinson

    Founded in 2012 and based in Toronto, Canada, Murchinson is an alternative asset management firm that serves institutional investors, family offices and qualified clients. The firm has extensive experience capturing the best returning opportunities across global markets. Murchinson's multi-strategy approach allows it to execute investments at all points in the market cycle with fluid allocation between strategies. Our team targets corporate action, distressed investing, private equity and structured finance situations, leveraging its broad market experience with a variety of specialized products and sophisticated hedging techniques to deliver alpha within a risk-averse mandate. Learn more at www.murchinsonltd.com.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward-looking information within the meaning of applicable securities laws. In general, forward-looking information refers to disclosure about future conditions, courses of action, and events. All statements contained in this press release that are not clearly historical in nature or that necessarily depend on future events are forward‐looking, and the use of any of the words "anticipates", "believes", "expects", "intends", "plans", "will", "would", and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations of Murchinson and currently available information. Forward-looking statements are not guarantees of future performance, involve certain risks and uncertainties that are difficult to predict, and are based upon assumptions as to future events that may not prove to be accurate. Murchinson undertakes no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

    Disclaimer

    The information contained or referenced herein is for information purposes only in order to provide the views of Murchinson and the matters which Murchinson believes to be of concern to shareholders described herein. The information is not tailored to specific investment objections, the financial situations, suitability, or particular need of any specific person(s) who may receive the information, and should not be taken as advice in considering the merits of any investment decision. The views expressed herein represent the views and opinions of Murchinson, whose opinions may change at any time and which are based on analyses of Murchinson and its advisors.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241028374105/en/

    Get the next $DM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What does Murchinson identify as the main issues with Nano Dimension Ltd.?

      Murchinson believes that urgent changes in Nano's boardroom are necessary due to ongoing value destruction, weak corporate governance, and mismanagement of resources.

    • Who are the nominees proposed by Murchinson for the Nano Board of Directors?

      Murchinson has nominated Robert (Bob) Pons and Ofir Baharav as independent candidates for the Nano Board of Directors for the upcoming 2024 Annual General Meeting.

    • What are Murchinson's goals with their board nominations for Nano Dimension?

      Murchinson aims to restore shareholder confidence by implementing better capital allocation processes and holding management accountable through independent oversight.

    • What was the outcome of the special general meeting regarding the removal of certain board members at Nano?

      Despite 85% of shareholders voting to remove certain board members, the CEO and others have refused to leave, showing disregard for shareholder sentiment.

    • What concerns does Murchinson raise regarding Nano's financial strategies?

      Murchinson argues that the Nano Board's spending on share repurchases has not improved the company’s valuation and that they have failed to address the ongoing share price stagnation.

    Recent Analyst Ratings for
    $DM
    $INSG
    $MCK
    $MKFG

    CompanyDatePrice TargetRatingAnalyst
    McKesson Corporation
    $MCK
    4/28/2026Outperform
    William Blair
    Inseego Corp.
    $INSG
    12/15/2025$17.00Buy
    Lake Street
    McKesson Corporation
    $MCK
    12/9/2025$960.00Overweight
    Barclays
    McKesson Corporation
    $MCK
    12/4/2024$630.00Neutral
    Mizuho
    Inseego Corp.
    $INSG
    11/14/2024$13.00 → $15.00Neutral → Buy
    ROTH MKM
    McKesson Corporation
    $MCK
    11/7/2024$531.00 → $688.00Neutral → Outperform
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/24/2024$603.00 → $531.00Outperform → Neutral
    Robert W. Baird
    McKesson Corporation
    $MCK
    9/5/2024$670.00 → $665.00Outperform
    Leerink Partners
    More analyst ratings

    $DM
    $INSG
    $MCK
    $MKFG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

    McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

    6/24/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Stratasys Advances Rail-Ready Additive Manufacturing With Certified Flame-Retardant FDM Material

    Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of FDM® PA6/66-GF30-FR, a new flame-retardant composite material designed to enable rail and transportation manufacturers to produce certified end-use parts and critical spare parts. The new material expands Stratasys' portfolio of industrial-grade, rail-ready FDM thermoplastics and is engineered specifically for use on Fortus® 450mc and F900® systems.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617094200/en/Rail-Ready Certified Flame-Retardant FDM MaterialDeveloped in response to long-standing collaboration with railway OEMs and service providers, the new material addre

    6/17/26 8:15:00 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    $DM
    $INSG
    $MCK
    $MKFG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Tyler Brian S. sold $6,559,925 worth of shares (8,463 units at $775.13) as part of a pre-agreed trading plan, decreasing direct ownership by 37% to 14,382 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/18/26 3:35:55 PM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Tyler Brian S. sold $3,760,827 worth of shares (4,929 units at $763.00) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 22,845 units (SEC Form 4)

    4 - MCKESSON CORP (0000927653) (Issuer)

    6/11/26 10:30:24 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Stehlin David covered exercise/tax liability with 19,841 units of Ordinary Shares, decreasing direct ownership by 3% to 762,003 units (SEC Form 4) to satisfy tax liability

    4 - Nano Dimension Ltd. (0001643303) (Issuer)

    6/10/26 4:15:18 PM ET
    $NNDM
    Electrical Products
    Technology

    $DM
    $INSG
    $MCK
    $MKFG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on McKesson

    William Blair initiated coverage of McKesson with a rating of Outperform

    4/28/26 7:45:38 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Lake Street initiated coverage on Inseego with a new price target

    Lake Street initiated coverage of Inseego with a rating of Buy and set a new price target of $17.00

    12/15/25 8:51:06 AM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    Barclays initiated coverage on McKesson with a new price target

    Barclays initiated coverage of McKesson with a rating of Overweight and set a new price target of $960.00

    12/9/25 8:51:34 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    $DM
    $INSG
    $MCK
    $MKFG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director North Sound Trading, Lp bought $479,504 worth of shares (55,001 units at $8.72) (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    8/14/25 7:08:42 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    CEO Sarvikas Juho bought $97,800 worth of shares (10,000 units at $9.78), increasing direct ownership by 8% to 134,347 units (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    3/5/25 4:05:10 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    Executive Chairman Brace Philip G bought $124,000 worth of shares (10,000 units at $12.40), increasing direct ownership by 6% to 177,763 units (SEC Form 4)

    4 - INSEEGO CORP. (0001022652) (Issuer)

    11/18/24 7:56:34 AM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    $DM
    $INSG
    $MCK
    $MKFG
    SEC Filings

    View All

    Inseego Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - INSEEGO CORP. (0001022652) (Filer)

    6/22/26 4:15:28 PM ET
    $INSG
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SCHEDULE 13D/A filed by Nano Dimension Ltd.

    SCHEDULE 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    6/17/26 8:48:37 PM ET
    $NNDM
    Electrical Products
    Technology

    SEC Form DEFA14A filed by Nano Dimension Ltd.

    DEFA14A - Nano Dimension Ltd. (0001643303) (Filer)

    6/17/26 4:06:08 PM ET
    $NNDM
    Electrical Products
    Technology

    $DM
    $INSG
    $MCK
    $MKFG
    Financials

    Live finance-specific insights

    View All

    McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date

    McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2027 financial results after market close on Wednesday, August 5, 2026. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson’s Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

    6/24/26 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

    Believes the Proposed Transaction Represents a Misallocation of Corporate Resources That Would Significantly Dilute Existing Shareholders Finds It Deeply Concerning That This Morning's Conference Call Offered Shareholders Little Beyond Buzzwords and Provided No Opportunity to Ask Questions Regarding a Transaction That Materially Impacts the Future of the Company Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term

    6/15/26 5:55:00 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

    Nano Dimension Conducted a Rigorous Multi-Month Strategic Review, Assessing Approximately 20 Companies Before Selecting Infinite Epigenetics as the Most Compelling Path to Long-Term Value CreationProposed Combination Would Deploy Nano Dimension's Capital Base and Nasdaq listing into a High-Growth Healthcare AI OpportunityExisting Nano Shareholders Expected to Retain Meaningful Minority Ownership in Combined Company on a Stated Value for Nano Dimension's Shares that Reflects a 20% Premium to Nano Dimension's Estimated Net Cash at ClosingInfinite Epigenetics Transaction Value of $890 million Infinite Epigenetics Targets a $90B+ U.S. Clinical Diagnostics Market Opportunity Across its Core Disea

    6/15/26 7:27:56 AM ET
    $NNDM
    Electrical Products
    Technology

    $DM
    $INSG
    $MCK
    $MKFG
    Leadership Updates

    Live Leadership Updates

    View All

    Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

    WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) ("Nano Dimension," "Nano", or the "Company") and Infinite Epigenetics™ ("Infinite Epigenetics," "Infinite") today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson's recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and com

    6/16/26 7:43:26 PM ET
    $NNDM
    Electrical Products
    Technology

    Nano Dimension Issues Letter to Shareholders

    Comments on Amended Schedule 13D Filing by Murchinson Strategic Alternatives Review Process Progresses WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (NASDAQ:NNDM) today issued the following letter to shareholders providing a business update and commenting on the Schedule 13D/A filing by Murchinson Ltd. and certain of its affiliates. The full text of the letter is below. Dear Fellow Shareholders, Nano Dimension Ltd. ("Nano" or the "Company") and its Board of Directors (the "Board") remain fully focused on executing the Company's previously announced strategic alternatives review process to maximize shareholder value and believe shareholders should understand the f

    5/26/26 8:00:00 AM ET
    $NNDM
    Electrical Products
    Technology

    SolarEdge Appoints Maoz Sigron as Chief Financial Officer

    SolarEdge Technologies, Inc. ("SolarEdge" or the "Company") (NASDAQ:SEDG), a global leader in smart energy technology, announced today the appointment of Mr. Maoz Sigron as the Company's new Chief Financial Officer (CFO), effective May 31, 2026. Maoz Sigron succeeds Mr. Asaf Alperovitz, who is stepping down from the role to pursue another professional opportunity outside of the industry. Asaf will remain with the Company through June 9, 2026 to assist with a smooth handover. Mr. Sigron has over 20 years of financial and operational experience across global organizations, with a strong track record in governance, M&A, capital markets, budgeting and operational discipline in NASDAQ- and TAS

    5/11/26 7:00:00 AM ET
    $ALLT
    $SEDG
    $SSYS
    Computer Communications Equipment
    Telecommunications
    Semiconductors
    Technology

    $DM
    $INSG
    $MCK
    $MKFG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/14/24 6:18:58 AM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Stratasys Ltd.

    SC 13G/A - STRATASYS LTD. (0001517396) (Subject)

    11/13/24 4:30:24 PM ET
    $SSYS
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13D/A filed by Nano Dimension Ltd.

    SC 13D/A - Nano Dimension Ltd. (0001643303) (Subject)

    11/13/24 11:31:24 AM ET
    $NNDM
    Electrical Products
    Technology